XML 60 R50.htm IDEA: XBRL DOCUMENT v3.25.2
Share-Based Compensation - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Millions
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Options granted (in shares) 1,470,812 1,951,377
Weighted-average grant date fair value of options granted (in usd per share) $ 0.85 $ 2.71
Weighted average exercise price of options granted (in usd per share) $ 1.00 $ 3.41
Options forfeited (in shares) 1,016,357 229,430
Options outstanding (in shares) 7,625,728 7,779,884
Weighted average exercise price of options outstanding (in usd per share) $ 5.30 $ 6.19
Unrecognized compensation cost related to options $ 2.0  
Stock options    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted-average period over which unrecognized compensation cost is expected to be recognized 2 years  
Barinthus Biotherapeutics plc Share Award Plan 2021 | Restricted share units, options, share appreciation rights and restricted shares    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Percentage of issued and outstanding ordinary shares available for issuance under the Plan 4.00%